To view biographies of the Senior Management, simply scroll below.
David Hamill, Executive ChairmanDavid Hamill joined Selecta as Executive Chairman in March 2017. David has been advising and managing Private Equity portfolio companies for ten years. Prior to joining Selecta, he was Chairman and Chief Executive Officer of ICI Paints and President and Chief Executive Officer of Philips Lighting.
David Flochel, Chief Executive OfficerDavid Flochel joined Selecta as Chief Executive Officer in July 2016. Prior to this David spent eight years at Mars Inc. and held several senior leadership positions, including Regional President North America and Europe of Mars Drinks. His other experience includes sales leadership roles at Unilever, and marketing roles at Anheuser-Busch InBev and L’Oreal.
Andreas Schneiter, Interim Chief Financial OfficerAndreas Schneiter joined Selecta as Interim Chief Financial Officer in January 2020. Prior to this Andreas was Group CFO of Dufry Group and a key Member of the Group Executive Committee, Investment Committee as well as holding board positions in many Dufry Group subsidiaries. Following completion of the interim CFO assignment, it is intended that Andreas will join the Board as Non-Executive Director and take the Chair of the Audit Committee.
Andy Ransom, Non-Executive DirectorAndy Ransom joined Selecta as a Non-Executive Director and Senior Independent Director to the Company’s Board in February 2019. He is currently Chief Executive Officer of Rentokil Initial, a FTSE 100 listed business. He was previously at ICI where he was appointed to the executive management team and had operational responsibility for ICI’s Regional and Industrial Division. Andy is also a Director and Trustee of Street League, and a Patron of Malaria No More UK.
Dorothée Deuring, Non-Executive DirectorDorothée Deuring joined Selecta as a Non-Executive Director in January 2020. She is a corporate finance specialist, with extensive experience and expertise in Corporate Finance and Investment Banking. She serves on the Board and Audit Committee of Bilfinger SE, Elementis plc and Axpo Holding AG and is a Board Member of Piqur Therapeutics AG.